News

Gut microbes from healthy human infant donors transplanted into mice protected animals exposed to milk from experiencing allergic reactions.

A new molecular approach has been identified which helps prevent rejection of transplanted organs, while simultaneously maintaining the ability to fight against infections.

A clinical trial has begun examining whether fecal microbiota transplantation by enema is safe and can prevent recurrent Clostridium difficile-associated disease, a potentially life-threatening diarrheal illness.

An assessment of data from babies born from pregnant women with and without 2009 H1N1 influenza infection during pregnancy has revealed fresh insights on the impact on the newborn.

Details of a new therapy for the symptomatic treatment of osteoarthritis have been revealed, using mesenchymal cells from umbilical cord stroma.

A new potential immunotherapy target has been identified for pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

A microfluidic liver-on-chip system which enables real-time measurement of cholesterol has been developed to study the effects of potentially cholesterol-lowering drugs in real time.

A previously unknown mechanism has been revealed for LL-37 and similar peptides, which are being tested in early-stage clinical trials for treating infections resistant to classical antibiotics.

An overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, providing important guidance for HIV prevention.

This gene therapy is similar to the technique the lab has used against another immune disease—severe combined immune deficiency, also known as bubble baby disease.